Aberrant expression and modification of silencing mediator of retinoic acid and thyroid hormone receptors involved in the pathogenesis of tumoral cortisol resistance

Endocrinology

Volumn 151, Issue 8, 2010, Pages 3697-3705

  Jiang, Jingjing ^a   Li, Na ^a   Wang, Xiaolin ^a   Lu, Yan ^a   Bi, Yufang ^a   Wang, Weiqing ^a   Li, Xiaoying ^a,b   Ning, Guang ^a,b  

^a Shanghai Institute of Pharmaceutical Industry   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 3; HYDROCORTISONE; PROOPIOMELANOCORTIN; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; SUMO PROTEIN;

ANIMAL CELL; ARTICLE; CARCINOID; CASE REPORT; CELL LINE; CONSENSUS SEQUENCE; CONTROLLED STUDY; DEXAMETHASONE SUPPRESSION TEST; ECTOPIC CORTICOTROPIN PRODUCTION; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENE SILENCING; GENETIC CONSERVATION; HORMONE RESISTANCE; HUMAN; HUMAN TISSUE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUMOYLATION; THYMOMA; THYMUS CARCINOID; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ACTH SYNDROME, ECTOPIC; ANIMALS; CARCINOID TUMOR; CELLS, CULTURED; DRUG RESISTANCE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HUMANS; HYDROCORTISONE; MICE; NUCLEAR RECEPTOR CO-REPRESSOR 2; PRO-OPIOMELANOCORTIN; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, SMALL INTERFERING; SUMO-1 PROTEIN; THYMUS NEOPLASMS; TRANSFECTION;

EID: 77954948400     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0335     Document Type: Article

References (34)

1. Wang WQ, Ye L, Bi YF, Zhao HY, Sun SY, Tang ZY, Zhao YJ, Fang WQ, Chen ZY, Chen KM, Jin XL, Ning G 2006 Six cases of ectopic ACTH syndrome caused by thymic carcinoid. J Endocrinol Invest 29:293-297
2. Ye L, Li X, Kong X, Wang W, Bi Y, Hu L, Cui B, Li X, Ning G 2005 Hypomethylation in the promoter region of POMC gene correlates with ectopic overexpression in thymic carcinoids. J Endocrinol 185: 337-343 (Pubitemid 40703873)
3. Lazar MA 2003 Nuclear receptor corepressors. Nucl Recept Signal 1:e001
4. YuJ, Li Y, Ishizuka T, Guenther MG, Lazar MA 2003 A SANT motif in the SMRT corepressor interprets the histone code and promotes histone deacetylation. EMBO J 22:3403-3410 (Pubitemid 36834870)
5. Guenther MG, Barak O, Lazar MA 2001 The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol Cell Biol 21:6091-6101 (Pubitemid 34263509)
6. Gill G 2004 SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev 18:2046-2059
7. Bohren KM, Nadkarni V, Song JH, Gabbay KH, Owerbach D 2004 A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J Biol Chem 279:27233-27238 (Pubitemid 38812561)
8. Johnson ES 2004 Protein modification by SUMO. Annu Rev Biochem 73:355-382
9. Hay RT 2005 SUMO: a history of modification. Mol Cell 18:1-12
10. Tiefenbach J, Novac N, Ducasse M, Eck M, Melchior F, Heinzel T 2006 SUMOylation of the corepressor N-CoR modulates its capacity to repress transcription. Mol Biol Cell 17:1643-1651 (Pubitemid 44011582)
11. Bi YF, Liu RX, Ye L, Fang H, Li XY, Wang WQ, Zhang J, Wang KK, Jiang L, Su TW, Chen ZY, Ning G 2009 Gene expression profiles of thymic neuroendocrine tumors (carcinoids) with ectopic ACTH syndrome reveal novel molecular mechanism. Endocr Relat Cancer 16: 1273-1282
12. Ki SH, Cho IJ, Choi DW, Kim SG 2005 Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPβTAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression. Mol Cell Biol 25:4150-4165
13. Fernández-Majada V, Aguilera C, Villanueva A, Vilardell F, Robert- Moreno A, Aytés A, Real FX, Capella G, Mayo MW, Espinosa L, Bigas A 2007 Nuclear IKK activity leads to dysregulated notchdependent gene expression in colorectal cancer. Proc Natl Acad Sci USA 104:276-281
14. Mukhopadhyay D, Dasso M 2007 Modification in reverse: the SUMO proteases. Trends Biochem Sci 32:286-295
15. Ren J, Gao X, Jin C, Zhu M, Wang X, Shaw A, Wen L, Yao X, Xue Y 2009 Systematic study of protein sumoylation: development of a site-specific predictor of SUMOsp 2.0. Proteomics 9:3409-3412
16. Xu J, He Y, Qiang B, Yuan J, Peng X, Pan XM 2008 A novel method for high accuracy sumoylation site prediction from protein sequences. BMC Bioinformatics 9:8
17. Hietakangas V, Anckar J, Blomster HA, Fujimoto M, Palvimo JJ, Nakai A, Sistonen L 2006 PDSM, a motif for phosphorylation-dependent SUMO modification. Proc Natl Acad Sci USA 103:45-50 (Pubitemid 43076102)
18. Jakobs A, Koehnke J, Himstedt F, Funk M, Korn B, Gaestel M, Niedenthal R 2007 Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation. Nat Methods 4:245-250 (Pubitemid 46358875)
19. Jakobs A, Himstedt F, Funk M, Korn B, Gaestel M, Niedenthal R 2007 Ubc9 fusion-directed SUMOylation identifies constitutive and inducible SUMOylation. Nucleic Acids Res 35:e109
20. Ruiz M, Lind U, Gåfvels M, Eggertsen G, Carlstedt-Duke J, Nilsson L, Holtmann M, Stierna P, Wikström AC, Werner S 2001 Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance. Clin Endocrinol (Oxf) 55:363-371
21. Charmandari E, Raji A, Kino T, Ichijo T, Tiulpakov A, Zachman K, Chrousos GP 2005 A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity. J Clin Endocrinol Metab 90:3696-3705 (Pubitemid 41014345)
22. Karl M, Lamberts SW, Koper JW, Katz DA, Huizenga NE, Kino T, Haddad BR, Hughes MR, Chrousos GP 1996 Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. Proc Assoc Am Physicians 108:296-307
23. Charmandari E, Kino T, Chrousos GP 2004 Familial/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms. Ann NY Acad Sci 1024:168-181 (Pubitemid 38879601)
24. Karl M, Von Wichert G, Kempter E, Katz DA, Reincke M, Mönig H, Ali IU, Stratakis CA, Oldfield EH, Chrousos GP, Schulte HM 1996 Nelson's syndrome associated with a somatic frame shift mutation in the glucocorticoid receptor gene. J Clin Endocrinol Metab 81:124-129
25. Dahia PL, Honegger J, Reincke M, Jacobs RA, Mirtella A, Fahlbusch R, Besser GM, Chew SL, Grossman AB 1997 Expression of glucocorticoid receptor gene isoforms in corticotropin-secreting tumors. J Clin Endocrinol Metab 82:1088-1093 (Pubitemid 27166647)
26. Gaitan D, DeBold CR, Turney MK, Zhou P, Orth DN, Kovacs WJ 1995 Glucocorticoid receptor structure and function in an adrenocorticotropin- secreting small cell lung cancer. Mol Endocrinol 9:1193-1201
27. Bilodeau S, Vallette-Kasic S, Gauthier Y, Figarella-Branger D, Brue T, Berthelet F, Lacroix A, Batista D, Stratakis C, Hanson J, Meij B, Drouin J 2006 Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. Genes Dev 20:2871-2886
28. Ordentlich P, Downes M, Evans RM 2001 Corepressors and nuclear hormone receptor function. Curr Top Microbiol Immunol 254:101-116
29. Privalsky ML 2004 The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu Rev Physiol 66:315-360 (Pubitemid 40614447)
30. Bawa-Khalfe T, Cheng J, Wang Z, Yeh ET 2007 Induction of the SUMO-specific protease 1 transcription by the androgen receptor in prostate cancer cells. J Biol Chem 282:37341-37349
31. Shan SF, Wang LF, Zhai JW, Qin Y, Ouyang HF, Kong YY, Liu J, Wang Y, Xie YH 2008 Modulation of transcriptional corepressor activity of prospero-related homeobox protein (Prox1) by SUMO modification. FEBS Lett 582:3723-3728
32. Park EJ, Schroen DJ, Yang M, Li H, Li L, Chen JD 1999 SMRTe, a silencing mediator for retinoid and thyroid hormone receptors-extended isoform that is more related to the nuclear receptor corepressor. Proc Natl Acad Sci USA 96:3519-3524 (Pubitemid 29168941)
33. Ordentlich P, Downes M, Xie W, Genin A, Spinner NB, Evans RM 1999 Unique forms of human and mouse nuclear receptor corepressor SMRT. Proc Natl Acad Sci USA 96:2639-2644 (Pubitemid 29148770)
34. Côté S, McNamara S, Brambilla D, Bianchini A, Rizzo G, del Rincón SV, Grignani F, Nervi C, Miller Jr WH 2004 Expression of SMRTβ promotes ligand-induced activation of mutated and wild-type retinoid receptors. Blood 104:4226-4235 (Pubitemid 39620177)